Mark A. Brown

8.6k total citations · 2 hit papers
130 papers, 4.9k citations indexed

About

Mark A. Brown is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Mark A. Brown has authored 130 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 22 papers in Pulmonary and Respiratory Medicine and 22 papers in Physiology. Recurrent topics in Mark A. Brown's work include Epigenetics and DNA Methylation (13 papers), Asthma and respiratory diseases (12 papers) and Cancer-related gene regulation (11 papers). Mark A. Brown is often cited by papers focused on Epigenetics and DNA Methylation (13 papers), Asthma and respiratory diseases (12 papers) and Cancer-related gene regulation (11 papers). Mark A. Brown collaborates with scholars based in United States, Sweden and Australia. Mark A. Brown's co-authors include John E. Casida, Philip W. Tucker, Derek W. Gammon, Robert J. Sims, Paul Gottlieb, Eneida A. Mendonça, Joseph J. Zorc, Anne Gadomski, Shawn L. Ralston and Kieran J. Phelan and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Environmental Science & Technology.

In The Last Decade

Mark A. Brown

125 papers receiving 4.7k citations

Hit Papers

Clinical Practice Guideline: T... 1993 2026 2004 2015 2014 1993 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Brown United States 29 1.1k 1.1k 1.1k 597 435 130 4.9k
Lu Zhang China 32 1.3k 1.2× 1.2k 1.1× 1.3k 1.2× 305 0.5× 164 0.4× 169 10.0k
Arthur L. Frank United States 35 1.7k 1.6× 1.2k 1.1× 1.2k 1.1× 287 0.5× 464 1.1× 146 6.9k
Lars Rydén Sweden 47 656 0.6× 572 0.5× 1.5k 1.4× 192 0.3× 411 0.9× 203 8.6k
Shinya Ito Canada 47 1.5k 1.3× 854 0.8× 1.6k 1.5× 156 0.3× 314 0.7× 309 8.9k
R. P. H. Thompson United Kingdom 42 719 0.7× 347 0.3× 743 0.7× 808 1.4× 253 0.6× 163 5.9k
Feng Guo China 31 694 0.6× 585 0.5× 1.6k 1.5× 564 0.9× 350 0.8× 148 5.9k
Tingting Gao China 29 641 0.6× 730 0.7× 1.5k 1.4× 411 0.7× 246 0.6× 169 8.7k
Harvey J. Cohen United States 51 883 0.8× 1.1k 1.1× 2.4k 2.3× 195 0.3× 691 1.6× 181 10.3k
Mostafa Ghanei Iran 40 322 0.3× 1.2k 1.1× 1.9k 1.8× 2.1k 3.5× 448 1.0× 316 6.1k
Dorine W. Swinkels Netherlands 67 1.1k 1.0× 1.2k 1.1× 2.5k 2.4× 329 0.6× 1.4k 3.1× 298 15.8k

Countries citing papers authored by Mark A. Brown

Since Specialization
Citations

This map shows the geographic impact of Mark A. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Brown more than expected).

Fields of papers citing papers by Mark A. Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Brown. The network helps show where Mark A. Brown may publish in the future.

Co-authorship network of co-authors of Mark A. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Brown. A scholar is included among the top collaborators of Mark A. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Brown. Mark A. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castro‐Rodríguez, José A., et al.. (2024). New paradigms in acute viral bronchiolitis: Is it time to change our approach?. Paediatric Respiratory Reviews. 56. 29–36. 2 indexed citations
2.
Zhu, Li, Mark A. Brown, Robert J. Sims, et al.. (2023). Lysine Methyltransferase SMYD1 Regulates Myogenesis via skNAC Methylation. Cells. 12(13). 1695–1695. 3 indexed citations
3.
Roess, Deborah A., et al.. (2023). Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases. Molecules. 28(4). 2000–2000. 11 indexed citations
4.
Brown, Mark A., et al.. (2020). The lysine methyltransferase SMYD2 is required for normal lymphocyte development and survival of hematopoietic leukemias. Genes and Immunity. 21(2). 119–130. 8 indexed citations
5.
Chan-Pérez, J.I., Antonio Ortega‐Pacheco, Eugenia Guzmán-Marı́n, et al.. (2019). Screening of Zoonotic Parasites in Playground Sandboxes of Public Parks from Subtropical Mexico. Journal of Parasitology Research. 2019. 1–6. 10 indexed citations
6.
Rhee, Catherine, Melissa A. Edwards, June Harris, et al.. (2016). ARID3A is required for mammalian placenta development. Developmental Biology. 422(2). 83–91. 24 indexed citations
7.
Brown, Mark A., et al.. (2015). Yersinia Pestis And The Westward Advance Of The Great Pestilence. International Journal of Sciences. 4(1). 18–19. 1 indexed citations
8.
Schmidt, Christian & Mark A. Brown. (2015). The Sins of Omission. Fraunhofer-Publica (Fraunhofer-Gesellschaft). 4(2). 1 indexed citations
9.
Brown, Mark A.. (2011). Science Versus Policy in Establishing Equitable Agent Orange Disability Compensation Policy. Military Medicine. 176(7S). 35–40. 5 indexed citations
10.
Brown, Mark A. & Christian Guilleminault. (2011). A Review of Sodium Oxybate and Baclofen in the Treatment of Sleep Disorders. Current Pharmaceutical Design. 17(15). 1430–1435. 18 indexed citations
11.
Brown, Mark A., et al.. (2010). Treatment Options for the Management of Exercise-Induced Asthma and Bronchoconstriction. The Physician and Sportsmedicine. 38(4). 74–80. 3 indexed citations
12.
Hull, Sara Chandros, Richard R. Sharp, Jeffrey R. Botkin, et al.. (2008). Patients' Views on Identifiability of Samples and Informed Consent for Genetic Research. The American Journal of Bioethics. 8(10). 62–70. 79 indexed citations
13.
Brown, Mark A., et al.. (2004). Correlation of human decidual and cord blood mononuclear cell cytokine production. Human Immunology. 65(11). 1336–1343. 12 indexed citations
14.
Brown, Mark A., et al.. (2003). Method of birth alters interferon‐gamma and interleukin‐12 production by cord blood mononuclear cells. Pediatric Allergy and Immunology. 14(2). 106–111. 21 indexed citations
15.
Stenflo, Johan, et al.. (2002). Post-translational processing of Drosophila nucleoside diphosphate kinase. Biochemical and Biophysical Research Communications. 295(3). 689–694. 5 indexed citations
16.
Halonen, Marilyn, et al.. (1999). Two Subphenotypes of Childhood Asthma That Differ in Maternal and Paternal Influences on Asthma Risk. American Journal of Respiratory and Critical Care Medicine. 160(2). 564–570. 70 indexed citations
17.
Greene, John N., et al.. (1997). Fever and Anorexia 10 Years After Major Trauma. Hospital Practice. 32(2). 32–34. 3 indexed citations
18.
Brown, Mark A., et al.. (1993). Predicting azo dye toxicity. Critical Reviews in Environmental Science and Technology. 23(3). 249–324. 649 indexed citations breakdown →
19.
Brown, Mark A.. (1987). Temperature-dependent Pyrethroid Resistance in a Pyrethroid-selected Colony of Heliothis virescens (F.) (Lepidoptera: Noctuidae). Journal of Economic Entomology. 80(2). 330–332. 22 indexed citations
20.
Brown, Mark A. & John E. Casida. (1987). Metabolism of a dicofol impurity α-chloro-DDT, but not dicofol or dechlorodicofol, to DDE in mice and a liver microsomal system. Xenobiotica. 17(10). 1169–1174. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026